| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 870,635 | 855,711 | 887,472 | 886,880 | | Cost of Revenue | 782,449 | 766,148 | 787,268 | 776,805 | | | Gross Profit | 88,186 | 89,563 | 100,204 | 110,075 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 64,736 | 64,265 | 71,387 | 79,956 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,952 | 2,680 | 2,823 | 4,292 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 20,498 | 22,618 | 25,994 | 25,827 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,566) |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 18,932 | 22,618 | 25,994 | 25,827 | | Interest Expense | 1,472 | 1,313 | 1,668 | 3,265 | | Income Before Tax | 17,460 | 21,305 | 24,326 | 22,562 | | Income Tax Expense | 5,060 | 8,256 | 9,571 | 7,746 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,400 | 13,049 | 14,755 | 14,816 | | | Non-recurring Events | | Discontinued Operations | (124) | (272) | (538) | (3,232) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,276 | 12,777 | 14,217 | 11,584 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,276 | $12,777 | $14,217 | $11,584 |
|
0.39% Nasdaq 
Income Statement
